Status: Recruiting
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
Participants needed: 14
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Qlaris Bio, Inc.Updated: Jul 6, 2026Locations: 1
Eligibility criteria
Diagnosis of mild to moderate OAG, mild to moderate NTG, or stable NPDR in at le... [+2]
History of active ocular disease other than mild to moderate OAG, mild to modera... [+8]